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Cobamides such as vitamin B12 (cobalamin) are pro-
duced exclusively by prokaryotes and used by many
other organisms as cofactors for diverse metabolic
processes. Cobamides are cobalt-containing tetra-
pyrroles with upper and lower axial ligands. The
structure of the lower ligand varies in cobamides pro-
duced by different bacteria. We investigated the
biochemical basis of this structural variability by
exploring the reactivity of homologs of CobT, the
enzyme responsible for activating lower ligand bases
for incorporation into cobamides. Our results show
that CobT enzymes can activate a range of lower
ligand substrates, and the majority of the enzymes
tested preferentially attach 5,6-dimethylbenzimida-
zole (DMB), the lower ligand of cobalamin. This sug-
gests that many bacteria that synthesize cobamides
other than cobalamin in pure culture may produce
cobalamin in mixed communities by attaching DMB
when it is available in the environment.
INTRODUCTION
Vitamin B12 (cobalamin 6, Figure 1A) is an essential cofactor for
a wide range of animals, protists, bacteria, and archaea. In
humans, cobalamin 6 is an essential micronutrient because of
its role as a cofactor for two major enzymes, methylmalonyl
CoA mutase and methionine synthase (Banerjee and Ragsdale,
2003). In bacteria, cobalamin 6 facilitates diverse metabolic pro-
cesses such as the biosynthesis and catabolism of amino acids,
modification of tRNA, reductive dehalogenation, and acetogen-
esis (Frey et al., 1988; Kra¨utler, 2005; Roth et al., 1996).
Cobalamin 6 is unique among the vitamins because it is syn-
thesized only by prokaryotes (Roth et al., 1996; Warren et al.,
2002). The structure of cobalamin 6 consists of a cobalt-contain-
ing corrin ring, an upper axial ligand, and a lower axial ligand that
is tethered to the corrin macrocycle via the nucleotide loop (Fig-
ure 1A) (Roth et al., 1996). Two coenzyme forms of cobalamin 6,
in which the upper ligand is either 50-deoxyadenosine or amethyl
group, catalyze radical and methyl transfer reactions, respec-
tively (Brown, 2005). Cobalamin 6 is a member of the cobamide
family of cofactors that have structural variability in the lowerChemistry & Biology 20, 1275–1ligand and the nucleotide loop (Kra¨utler et al., 2003; Renz,
1999). The lower ligands of cobamides identified thus far belong
to three chemical classes: benzimidazoles, purines, and pheno-
lics (Figure 1B) (Renz, 1999). Cobamide-synthesizing organisms
typically produce cobamides with only one or two different lower
ligands when grown in pure culture. Although it is known that a
variety of cobamides are present in complex microbial commu-
nities, important questions remain regarding the molecular fac-
tors responsible for specificity in the structure of the lower ligand
(Allen and Stabler, 2008; Girard et al., 2009; Herbert et al., 1984).
The function of 5,6-dimethylbenzimidazole (DMB 1), the lower
ligand of cobalamin 6 (the best studied cobamide), has been
investigated in several cobamide-dependent enzymes (Kra¨utler,
1990, 2009). In enzymes such as class II ribonucleotide reduc-
tase, diol dehydratase, and ethanolamine ammonia lyase, cobal-
amin 6 has been shown to bind in the ‘‘base-on’’ form, in which a
nitrogen atom in DMB 1 is coordinated to the cobalt center, as
shown in Figure 1A (Abend et al., 1999; Lawrence et al., 1999;
Martens et al., 2002; Yamanishi et al., 1998). Other enzymes,
such as cobalamin-dependent methionine synthase, methylma-
lonyl CoAmutase, andglutamatemutase, bindcobalamin 6 in the
‘‘base-off’’ form, in which DMB 1 is not coordinated to the cobalt
center but remains covalently attached to the nucleotide loop
(Drennan et al., 1994; Mancia et al., 1996; Tollinger et al., 2001).
In both base-on and base-off enzymes, the structure of the lower
ligandmay affect the binding and catalytic ability of the cobamide
cofactor (Hamza et al., 2005; Kra¨utler and Ostermann, 2003).
Because the structure of the lower ligand affects cobamide func-
tion, in some cases bacteria have mechanisms to limit cobamide
production to those forms that support their enzymatic functions
(Chan and Escalante-Semerena, 2011; Gray and Escalante-
Semerena, 2009a; Mok and Taga, 2013). In the accompanying
article by Crofts et al. (2013, in this issue ofChemistry & Biology),
we report that the range of cobamides that can be synthesized in
several bacteria is limited by molecular factors encoded by the
cobT gene. The CobT enzyme catalyzes the activation of the
lower ligand base by phosphoribosylation to form an a-ribosy-
lated product (Fyfe and Friedmann, 1969; Trzebiatowski and
Escalante-Semerena, 1997). The a-ribosylated product is subse-
quently incorporated as the lower ligand of the cobamide
(Cameron et al., 1991). X-ray crystallographic studies of
Salmonella enterica CobT showed that several benzimidazoles,
purines, and phenolic compounds can be bound in the active
site, and all but the phenolic compounds can be used as sub-
strates for phosphoribosylation (Cheong et al., 2001). The
inability of Sa. enterica to activate phenolic compounds is285, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1275
Figure 1. Activation and Attachment of Cobamide Lower Ligands
(A) The reaction catalyzed by CobT is shown with substrates DMB 1 and NaMN 2, which form the products nicotinic acid 3 and a-RP 4. a-RP 4 is subsequently
attached to the cobamide precursor, 5’-deoxyadenosylcobinamide-guanosine diphosphate (GDP-Cbi 5), to form cobalamin 6.
(B) CobT catalyzes the activation of several other lower ligand bases to form the corresponding a-riboside phosphate products. The structures of the lower ligand
bases used in this study and the corresponding a-riboside phosphate products are shown. The name of each compound is given with abbreviations in
parentheses.
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Substrate Specificity of CobTsignificant because Sa. enterica is unable to use phenolyl coba-
mides (Chan and Escalante-Semerena, 2011). In contrast, the
ArsAB enzyme of Sporomusa ovata can activate both DMB 1
and phenolic compounds, despite the fact that growth of Sp.
ovata on several substrates is impaired when benzimidazolyl
cobamides are produced instead of phenolyl cobamides (Chan
and Escalante-Semerena, 2011; Mok and Taga, 2013).
In the accompanying article by Crofts et al. (2013), we describe
a genetic analysis of six cobT homologs derived from phyloge-1276 Chemistry & Biology 20, 1275–1285, October 24, 2013 ª2013 Enetically diverse organisms. We showed that the cobT gene
controls the range of lower ligand bases that can be attached
to form cobamides using heterologous expression studies in
Sinorhizobium meliloti as well as studies in the native organism.
This analysis revealed differences in the ability of the CobT
homologs to activate lower ligand substrates but did not
compare preferences for the different substrates. In the present
study, we characterize the substrate specificity of the CobT
enzyme homologs in vitro in order to test the hypothesis thatlsevier Ltd All rights reserved
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corresponding to the cobamide that is produced by the organ-
ism. The chosen enzymes are from six phylogenetically diverse
bacteria that synthesize cobamides with lower ligands that
collectively represent all three structural classes (Figure 1B).
The bacteria analyzed includeSi.meliloti, which produces cobal-
amin 6 (Kliewer and Evans, 1962); Sa. enterica, which produces
pseudo-B12 ([Ade]Cba) and 2-methyladeninyl cobamide (Keck
and Renz, 2000); Lactobacillus reuteri, which produces [Ade]
Cba (Santos et al., 2007); Desulfovibrio vulgaris, which produces
guanyl cobamide and hypoxanthyl cobamide (Guimara˜es et al.,
1994); and Dehalococcoides mccartyi, which produces benzimi-
dazolyl cobamides only when cultured with a cobamide precur-
sor and a benzimidazole (Yi et al., 2012). The CobT homologs
from these five organisms will be abbreviated as SmCobU,
SeCobT, LrCobT, DvCobT, and DmCobT, respectively. We
also analyzed two CobT enzymes of Veillonella parvula, which
synthesizes cobamides with p-cresol (Cre, 19) and benzimid-
azole (Bza, 13) as the lower ligands. One CobT enzyme of
V. parvula, VpCobT, is unable to activate phenolic compounds,
whereas the other, VpArsAB, is capable of activating phenolic
compounds and appears to function as a heterodimer of the
arsA and arsB gene products, similar to the previously character-
ized ArsAB enzyme of Sp. ovata (Chan and Escalante-Semer-
ena, 2011; Newmister et al., 2012, Crofts et al., 2013). Our results
show that, surprisingly, six of the seven CobT enzymes tested
display a strong preference for DMB 1, despite the fact that
cobalamin 6 is not synthesized by the majority of these bacteria.
Moreover, adenine (Ade 15), which is the lower ligand of the
cobamide produced by both Sa. enterica and L. reuteri, is the
least preferred substrate of the CobT homologs of all of the bac-
teria tested. These results indicate that bacteria may be capable
of activating a wide range of lower ligand substrates and that
DMB 1 may be preferentially attached as a lower ligand when
it is available in the environment.
RESULTS
Characterization of the Formation of a-Ribazole
Phosphate by SmCobU
Previous in vitro studies of the biosynthesis of a-ribazole phos-
phate (a-RP 4) with cell extracts of Propionibacterium shermanii
(Friedmann, 1965) and purified SeCobT (Trzebiatowski and
Escalante-Semerena, 1997) used radioactive thin layer chroma-
tography to resolve 14C-labeled DMB 1 and a-RP 4. Because we
sought to analyze reactions with multiple substrates that are
commercially available only in their unlabeled form, we devel-
oped a high-performance liquid chromatography (HPLC)-based
assay that is capable of resolving all of the substrates and prod-
ucts shown in Figure 1. In the reaction containing purified
SmCobU and the substrates DMB 1 and nicotinate mononucle-
otide (NaMN 2), the substrates were nearly completely elimi-
nated, and three products were formed (Figure 2A). One product
co-elutes with the nicotinic acid 3 standard and was also formed
in the reaction lacking DMB 1, suggesting that hydrolysis of
NaMN 2 to nicotinic acid 3 could be achieved by SmCobU in
the absence of DMB 1, as observed previously with SeCobT
(Cheong et al., 1999) (Figure 2A). The other two products are
not present in control reactions lacking either the enzyme orChemistry & Biology 20, 1275–1one of the substrates and did not co-elute with any of the
standards (Figure 2A).
We performed liquid chromatography electrospray ionization
mass spectrometry (LC-ESI-MS) analysis on the reactions
shown in Figure 2A to identify the two reaction products. A com-
pound corresponding to the m/z 359.1 expected for a-RP 4 was
detected at 8 min (the same retention time as the second peak in
Figure 2A) in the full reaction but was absent in the control reac-
tions (Figure 2B). The total ion spectrum for the peak at 8 min
showed a species with an m/z of 359.1 corresponding to a-RP
4 and another species at 381.1 corresponding to its Na-adduct
(Figure 2C). An additional in-source fragmentation product with
the m/z 147.1 expected for DMB 1 was also observed (Fig-
ure 2C). We purified the peak at 8 min by HPLC from a large-
scale reaction and analyzed it by one-dimensional 1H NMR.
The spectrum obtained and the integration of the proton signals
were consistent with the structure of a-RP 4 (Figure 2D). Analysis
of the reaction product that eluted at 14 min (Figure 2A) showed
that it is likely to have resulted from dephosphorylation of a-RP 4,
as its retention time is consistent with it being less polar than
a-RP 4 due to the loss of the phosphate group, and the m/z
corresponds to that of a-ribazole (data not shown). This peak
appears only in reactions that proceed for 48 hr or longer, sug-
gesting that it is the result of spontaneous nonenzymatic hydro-
lysis of a-RP 4.
Previous studies of SeCobT have shown that DMB 1 can be
activated with multiple mono- and dinucleotide cosubstrates
such as NaMN 2, nicotinamide mononucleotide (NMN 23), nico-
tinate adenine dinucleotide (NaAD 21), and nicotinamide adenine
dinucleotide (NAD 25), although the specific activity of SeCobT
with NaMN 2 or NMN 23 was higher than with NaAD 21 or
NAD 25 (Figure S1; Maggio-Hall and Escalante-Semerena,
2003). As the present study focuses on the lower ligand sub-
strates, we aimed to select one of the four riboside phosphate
cosubstrates to use for the analysis of all seven CobT homologs.
The reactivity of each cosubstrate was determined for SmCobU
and SeCobT with DMB 1 as the lower ligand substrate. The
corresponding ribosylated products were formed in all four
reactions after 48 hr (Figure S1 available online), but product
formation occurred after 1 min only in reactions containing
NaMN 2 and NMN 23 (data not shown). We further tested the
reactivity of SmCobU, SeCobT, DmCobT, and DeCobT with
cosubstrates NaMN, NMN, and NAD for the other four benzimid-
azole bases and adenine and found that NAD did not react
with any of the bases tested and only NaMN and NMN gave
products for all the bases. Additionally, as observed previously
with SeCobT, we found that the reaction of SmCobU with
NaMN 2 was faster than with NMN 23 (data not shown)
(Maggio-Hall and Escalante-Semerena, 2003). Therefore,
NaMN 2 was used for all subsequent reactions.
Next, to determine the reactivity of SmCobU with each lower
ligand substrate, reactions were performed with NaMN 2 and
each of the lower ligand bases shown in Figure 1B. HPLC anal-
ysis showed the formation of a product with a unique retention
time in each reaction except in those containing phenol (Phe
17) or Cre 19 (Figure 3A). In all cases, LC-ESI-MS and one-
dimensional 1H NMR analysis confirmed the identity of the
a-riboside phosphate product corresponding to the lower ligand
substrate used in each reaction (Figures S2A–S2E).285, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1277
Figure 2. Reaction Catalyzed by SmCobU
(A) HPLC analysis of the reaction containing SmCobU, DMB 1, and NaMN 2 is shown. Also shown are control reactions lacking each component and the
standards for DMB 1, NaMN 2, and nicotinic acid 3.
(B)PositivemodeLC-ESI-MSof the reactioncontainingSmCobU,DMB1, andNaMN2 showing theextracted ioncount form/z359.1,whichcorresponds toa-RP4.
(C) Total ion spectrum of the a-RP 4 peak at 8 min displays peaks at m/z 359.1, 381.1 and 147.2, which correspond to a-RP 4, Na-adduct of a-RP 4, and DMB 1,
respectively.
(D) 1H NMR analysis of purified a-RP 4 is shown. The spectrum shows the ribose ring protons (HE 6.4 ppm s, HF 4.6 ppmm, HG 4.5 ppmm, HH 4.4 ppmm, HI, HJ
4.0 ppm dd), the benzimidazole ring protons (HA 8.4 ppm s, HB 7.51 ppm s, 7.45 ppm s) and methyl group protons (HC 2.34 ppm d), consistent with the expected
structure of a-RP 4. The residual NH4OAc buffer peak is visible at 1.91 ppm.
See also Figure S1.
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Their Ability to Activate a Range of Lower Ligand
Substrates
To compare the reactivity of the other six CobT enzymes, each
enzyme was purified and tested in reactions containing NaMN
2 and each of the eight lower ligand bases shown in Figure 1.
The reactions were analyzed by HPLC as described above. In
addition to the benzimidazole substrates and Ade 15, our
HPLC method also resolved the phenolic substrates and corre-
sponding products, as shown in reactions containing VpArsAB
(Figure 3B). The reactivity of each enzyme was calculated based
on the percent depletion of the lower ligand substrate after 48 hr
(Table S1). This analysis showed that all of the enzymes were
capable of activating all five benzimidazoles and Ade 15, but
only the VpArsAB enzyme could activate Phe 17 and Cre 19 (Fig-1278 Chemistry & Biology 20, 1275–1285, October 24, 2013 ª2013 Eure 3B; Table S1). The reaction containing purified VpArsA
showed neither NaMN 2 hydrolysis nor formation of a-RP 4
(data not shown), consistent with previous studies (Chan and
Escalante-Semerena, 2011; Crofts et al., 2013). Most of the
enzymes showed over 90% depletion of the lower ligand sub-
strate (Table S1). The reactions that did not go to completion
may indicate a slow rate of conversion or instability of the
enzyme over the reaction time. We verified the identity of each
a-riboside phosphate product by LC-ESI-MS and one-dimen-
sional 1H NMR (Figures S2A–S2G).
Quantitative Determination of the Relative Preferences
of CobT Enzyme Homologs for Lower Ligand Substrates
We next determined the relative preference of each CobT
enzyme for each lower ligand substrate by performing reactionslsevier Ltd All rights reserved
Figure 3. Activation of Lower Ligand Bases by CobT Enzymes
(A) HPLC analysis of reactions containing SmCobU, NaMN 2, and the indi-
cated lower ligand substrates are shown. Black traces show control reactions
in which SmCobU is absent, and gray traces show complete reactions.
Numbers correspond to the compounds shown in Figure 1.
(B) Reactions containing VpArsAB, NaMN 2, and phenolic substrates are
shown. Numbers above peaks represent compounds verified by LC-ESI-MS.
See also Figure S2 and Table S1.
Figure 4. HPLC Analysis of a Competition Reaction between DMB 1
and MeBza 7
Reactions containing SmCobU, NaMN 2, and equimolar amounts of DMB 1
and MeBza 7 were quenched at the indicated time points. The amplified inset
shows the product peaks a-RP 4 and MeBza-RP 8 (indicated by the boxes)
that are formed from the corresponding lower ligand substrate. The nicotinic
acid 3 present in the t = 0 reaction was formed in the process of quenching the
reaction. Numbers above peaks represent compounds verified by LC-ESI-MS.
See also Figure S3.
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under steady state conditions. These pairwise competition reac-
tions were carried out with all combinations of lower ligand sub-
strates that showed reactivity in Table S1. HPLC analysis of a
representative competition reaction containing SmCobU with
DMB 1 and 5-methylbenzimidazole (MeBza 7) is shown in Fig-
ure 4. In this reaction, DMB 1 appears to be used preferentially
compared to MeBza 7, because the peak corresponding to the
DMB 1 reaction product, a-RP 4, is substantially larger than
5-methylbenzimidazole riboside phosphate (MeBza-RP 8) after
1 min (Figure 4). By 48 hr, both substrates were nearlyChemistry & Biology 20, 1275–1completely converted to the corresponding a-riboside phos-
phate products (Figure 4).
In order to calculate the ratios of products formed in each
competition reaction, the concentrations of the a-riboside phos-
phate products formed in each reaction after 1 min were deter-
mined based on their HPLC peak areas. These compounds are
not commercially available for use as standards, and their UV-
Vis spectra differ considerably from the corresponding lower
ligand base (Figure S3). Therefore, to measure the concentra-
tions of the a-riboside phosphate products formed, the concen-
tration of each purified compound was determined by Electronic
REference To access In vivo Concentrations (ERETIC) NMR, and
a standard curve was generated for each a-riboside phosphate
product as described in Experimental Procedures. The molar
ratios calculated for each a-riboside phosphate product formed
in the competition reactions containing SmCobU are shown in
Table 1. We found that in all reactions containing DMB 1 and
another substrate, a-RP 4 was formed in higher amounts than
the other a-riboside phosphate product (Table 1). SmCobU
also showed distinct preferences among the other lower ligand
substrates, with all of the benzimidazoles preferred over285, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1279
Table 1. Pairwise Competition Reactions with SmCobU
DMB MeBza OMeBza Bza OHBza
MeBza 2.4 ± 0.2
OMeBza 39 ± 3 17.3 ± 0.4
Bza 163 ± 0.7 55 ± 3 3.6 ± 0.1
OHBza 172 ± 31 357 ± 21 81 ± 5 32 ± 1
Ade 400 ± 14 >287a >232a >128a >146a
The ratio of products formed after 1 min in reactions containing two lower
ligand substrates is shown forSmCobU. Themolar ratio of the concentra-
tion of the a-riboside phosphate products formed in each pairwise lower
ligand substrate competition reaction is given (column:row). Numbers
represent the average of three independent experiments with SE. See
also Table S2 for the ratio of products formed after 1min in reactions con-
taining two lower ligand substrates for all the other CobT enzymes.
aAde-RP was not detected. The value given is based on the detection
limit of the assay.
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Substrate Specificity of CobTAde 15 (Table 1). The results of pairwise competition reactions
performed with the other CobT enzyme homologs are shown in
Table S2.
The ratios of products formed in each pairwise competition
reaction were used to calculate the overall percent preference
of each CobT enzyme for each lower ligand substrate (Figure 5).
Surprisingly, the overall preferences of six of the seven en-
zymes are remarkably similar, with all showing a strong prefer-
ence for DMB 1 (68%–77%), despite the fact that only one of
the CobT homologs, SmCobU, is derived from an organism
that synthesizes cobalamin 6 de novo (Figures 5A–5F). In five
of these six enzymes, MeBza 7 is the second most preferred
substrate, and the preference for the other benzimidazoles
totals <10%. The only exception to this trend is VpArsAB,
which shows similar preference for its native lower ligand,
Cre 19, and four of the benzimidazoles (Figure 5G). Interest-
ingly, Ade 15 is the least preferred substrate of all of the
CobT homologs.
Competition for Benzimidazoles in Si. meliloti Cultures
Validates In Vitro Results
We next sought to test whether the substrate preferences
observed in vitro reflect the preferences of bacteria for the
incorporation of lower ligand bases into cobamides. The Si.
meliloti bluB mutant was used to assay the relative level of
incorporation of DMB 1 and other lower ligand bases into coba-
mides. The bluB mutant is incapable of producing DMB 1 and
does not produce a cobamide unless a lower ligand base is pro-
vided (Campbell et al., 2006). Only the benzimidazoles were
tested because the presence of endogenously synthesized
Ade 15 precluded the manipulation of Ade 15 concentrations.
Cultures of the Si. meliloti bluB mutant strain were supple-
mented with both DMB 1 and a competing benzimidazole
base at molar ratios varying from 104 to 1, and corrinoids
were extracted and analyzed by HPLC to measure the ratios
of the cobamides produced. We found that, consistent with
the in vitro experiments, DMB 1 was greatly preferred over
the other benzimidazoles (Figure 6). The ratio of substrates
that resulted in equal concentrations of the two cobamides pro-
duced (SD50) was calculated for each benzimidazole (Figure 6).
This analysis showed that MeBza 7 was the second most1280 Chemistry & Biology 20, 1275–1285, October 24, 2013 ª2013 Epreferred substrate, with Bza 13, OHBza 9, and OMeBza 11
incorporated less favorably, similar to SmCobU analyzed
in vitro (compare Figures 5A and 6).
DISCUSSION
The synthesis of cobamide cofactors is exclusive to prokaryotes,
and cobamide-producing organisms studied to date are known
to synthesize only one or two different cobamides (Martens
et al., 2002). Cobamides have been characterized extensively
for the reactivity conferred by the upper ligand, but the role of
the lower ligand in catalysis and the biochemical basis of the
diversity in lower ligand structure have been relatively less stud-
ied. The accompanying article by Crofts et al. (2013) shows that
the range of lower ligand bases that can be attached to form
cobamides is limited by the substrate specificity of CobT. In
this article, we examine the relative preferences of the CobT
enzymes for the different lower ligand bases. We tested seven
CobT enzyme homologs in vitro in order to understand how sub-
strate preferences differ among CobT enzymes. These enzymes
were chosen because they are derived from bacteria that collec-
tively synthesizeadiverse rangeof cobamides inpureculture.We
expected that each enzyme would have highest preference
for the lower ligand base found in the cobamide native to each
organism. However, we were surprised to find that six of the
enzymes exhibit remarkably similar substrate preferences and
have a considerably higher preference for DMB 1. The benzimid-
azole substrate competition in cultures of Si. meliloti bluB also
confirmed the preference for DMB 1 in comparison to other
benzimidazoles.
The ability of CobT homologs to activate a limited range of
lower ligand bases is important because not all cobamides are
functionally equivalent. For example, the methionine synthase
of Arthrospira platensis shows a higher affinity for [Ade]Cba
than cobalamin 6, whereas Rhodobacter sphaeroides requires
cobalamin 6 and is incapable of using [Ade]Cba (Gray and Esca-
lante-Semerena, 2009b; Tanioka et al., 2010). In addition, we
recently found that Sp. ovata requires phenolyl cobamides
when using certain carbon sources and that only three benzimi-
dazolyl cobamides can be utilized by Dc. mccartyi (Mok and
Taga, 2013; Yi et al., 2012). Similarly, in the accompanying article
by Crofts et al. (2013), we find that the degree to which different
cobamides support the growth of Si. meliloti varies. These differ-
ences in cobamide function may suggest adaptations of coba-
mide-dependent enzymes for specific cobamides on the basis
of their lower ligands.
Based on these observations that cobamide-dependent
enzymes in different bacteria are optimized for the use of
different cobamides, it is surprising that the CobT enzyme homo-
logs tested in this study show a nearly universal preference for
DMB 1. Our results suggest that bacteria that preferentially acti-
vate DMB 1 may produce cobalamin 6 when DMB 1 is available
in the environment, as is the case for Sa. enterica (Anderson
et al., 2008). The preference of CobT for DMB 1 may indicate
that cobalamin 6 functions more effectively than other coba-
mides in a wide variety of organisms. However, the production
of cobalamin 6 by the incorporation of exogenous DMB 1 may
not benefit some bacteria, as we have observed in Sp. ovata
(Mok and Taga, 2013). It remains unclear whether the use oflsevier Ltd All rights reserved
Figure 5. Overall Lower Ligand Substrate
Preferences for Each CobT Enzyme Homo-
log under Conditions Assayed
The relative percent preference for each substrate
was calculated from the ratios of a-riboside
phosphate products in pairwise competition re-
actions with all combinations of lower ligand
substrates for each purified CobT enzyme homo-
log under the same assay conditions. The ratios of
products formed in each set of pairwise competi-
tion reactions are presented in Tables 1 and S2.
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Substrate Specificity of CobTcobamides other than cobalamin 6 is an early or relatively recent
evolutionary adaptation.
Our analysis showed that VpArsAB has distinct substrate pref-
erences compared to the other six CobT enzymes tested and is
the only enzyme in this study that is capable of activating
phenolic compounds. The function of VpArsAB is similar to the
well-characterized ArsAB enzyme from Sp. ovata in its ability
to catalyze the phosphoribosylation of both phenolic com-
pounds and benzimidazoles to form O-linked and N-linked
glycosidic bonds, respectively. In contrast, phenolic compounds
inhibit the hydrolysis of NaMN 2 in the other six CobT homologs,
possibly due to their binding in the active site in an orientation
such that water is excluded, as previously observed in a struc-
tural study of SeCobT (Cheong et al., 2001, 2002). The ability
of ArsAB to activate phenolic compounds is likely due to struc-
tural features unique to the ArsAB heterodimer and the identities
and positions of key active site residues (Cheong et al., 1999;
Newmister et al., 2012). Despite the apparent specialization of
ArsAB for the activation of phenolic compounds, it is interesting
to note that VpArsAB has slightly higher preference for three of
the benzimidazoles compared to the phenolic compounds. The
fact that V. parvula also possesses the VpCobT enzyme that
has a higher preference for benzimidazoles suggests that the
ability of VpArsAB to activate benzimidazoles could be a vestigial
function (Na¨svall et al., 2012).Chemistry & Biology 20, 1275–1285, October 24, 2013 ªDvCobT was included in this study
because Dv. vulgaris is the only organism
reported to synthesize guanyl and hypo-
xanthyl cobamides (Guimara˜es et al.,
1994). However, we were surprised to
find that neither guanine nor hypoxan-
thine could be used as a substrate for
DvCobT in vitro or in a Si. meliloti strain
expressing Dv. vulgaris cobT (data not
shown). It is possible that Dv. vulgaris
possesses an enzyme other thanDvCobT
that activates guanine and hypoxanthine
for incorporation into cobamides, analo-
gous to V. parvula, which has two CobT
enzymes with different substrate speci-
ficities. Although no other cobT homolog
appears to be present in the Dv. vulgaris
genome, a novel gene may be respon-
sible for this activity.
The results of this in vitro study are
largely consistent with our analysis oflower ligand attachment in the accompanying article (Crofts
et al., 2013). The lower ligand attachment profiles of the CobT
homologs measured in Si. meliloti and in vitro are parallel except
thatAde15canbeusedasasubstratebyall of theCobTenzymes
in vitro, whereas [Ade]Cba is produced only by some of the Si.
meliloti strains expressing cobT homologs (Crofts et al., 2013).
Based on our studies of the reactivity of the CobT homologs
with various lower ligand substrates (Table S1) and the competi-
tion assays indicating that Ade 15 is far less preferred relative
to the other substrates (Figure 5), it is likely that [Ade]Cba is syn-
thesized by all of the Si. meliloti strains, but in some cases at
quantities that could not be detected by our methods.
A possible explanation for the preference of the CobT
enzymes for benzimidazoles over Ade 15 is that cobamides
other than [Ade]Cba function more efficiently as cofactors in
these organisms. If this is the case, the lower affinity of CobT
enzymes for Ade 15 may serve to prevent cells from incorpo-
rating Ade 15,which is available in the cell, when more favorable
lower ligand bases are present. This hypothesis is consistent
with previous observations that Sa. enterica attaches DMB 1
instead of Ade 15 when DMB 1 is available and that both cobal-
amin 6 and [Ade]Cba function in Sa. enterica (Anderson et al.,
2008). It is also consistent with our results in Si. meliloti, but
not in L. reuteri, which is unable to incorporate benzimidazoles
into cobamides (Santos et al., 2007; Crofts et al., 2013).2013 Elsevier Ltd All rights reserved 1281
Figure 6. Competition for Lower Ligand Attachment in Si. meliloti
The Si. meliloti bluB mutant was cultured with DMB 1 and another benzimid-
azole at different ratios prior to corrinoid extraction and HPLC analysis. Each
point shows the relative amount of cobalamin 6 present in a culture containing
DMB 1 and another benzimidazole at the ratio indicated on the x-axis, ex-
pressed as a percentage of the total cobamides in the culture. The calculated
SD50 values, which represent the percent DMB 1 added to cultures that would
result in the production of equal levels of the two cobamides, are given for each
competing benzimidazole. The dashed vertical line is drawn at the point
representing equal levels of DMB 1 and the competing benzimidazole.
See also Table S3.
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reactions in which two lower ligand substrates are in direct
competition for a limited amount of CobT enzyme. These reac-
tions maymimic environmental conditions in which multiple sub-
strates for CobT are available. CobT presumably encounters
multiple potential substrates in bacteria that synthesize benzimi-
dazolyl or phenolyl cobamides because other bases such as Ade
15 are also present in the cell. Consistent with this idea, we have
detected free benzimidazoles in microbial communities, indi-
cating that benzimidazole bases are available in some environ-
ments (Y. Men, E.C. Seth., S. Yi, T.S.C., R.H. Allen, M.E.T., and
L. Alvarez-Cohen, unpublished data). Based on this observation,
it is possible that benzimidazolyl cobamides are produced in the
environment by bacteria that are incapable of synthesizing
benzimidazoles. However, [Ade]Cba has also been found in sig-
nificant proportions in several environments, indicating that a
subpopulation in the community produces [Ade]Cba even
when DMB 1 is present (Allen and Stabler, 2008; Girard et al.,
2009; Y. Men, E.C. Seth., S. Yi, T.S.C., R.H. Allen, M.E.T., and
L. Alvarez-Cohen, unpublished data).
The cobamide family of cofactors is unique in that the structure
of the lower ligand, a site removed from the catalytic center,
varies depending on the organism. Although structural variability
has been observed in cofactors such as heme, NAD/NADP, fla-
vins, and pterins, extensive organism-specific variability has only
been observed in cobamides (Bowman and Bren, 2008; Carugo
and Argos, 1997; Kritsky et al., 2010; Li et al., 2011). Cobamides
are also unique in that their biosynthesis is restricted to less than
half of the bacteria that use them and requires the investment of
a significant proportion of the genome (Lawrence and Roth,
1996; Zhang et al., 2009). For these reasons, bacteria may
have evolved to synthesize and use specific cobamides as a
means of preventing competitive sequestration of cobamides
by other organisms or promoting cooperative interactions with1282 Chemistry & Biology 20, 1275–1285, October 24, 2013 ª2013 Eorganisms that require specific cobamides. Further studies of
the functions of structurally diverse variants of these cofactors
will be necessary to understand their roles in catalysis and in
the environment.
SIGNIFICANCE
Vitamin B12 (cobalamin) is a member of the cobamide family
of cofactors that function in diverse biological processes
with applications in natural product biosynthesis, bioreme-
diation, biofuels production, and medicine. Cobamides
consist of a cobalt-containing corrin ring and upper and
lower axial ligands. The lower ligand is structurally variable
in the cobamides produced by different bacteria. Here, we
have explored the biochemical basis of this structural vari-
ability.We analyzed the substrate specificity of seven homo-
logs of CobT, the enzyme that catalyzes the activation of the
lower ligand base prior to incorporation into a cobamide.
Based on the results of competition assays with pairs of
lower ligand substrates, we found that six of the seven
CobT enzymes have a higher preference for 5,6-dimethyl-
benzimidazole (DMB), the lower ligand of cobalamin,
compared to the other seven substrates tested. This nearly
universal preference for DMB is surprising because most
bacteria produce cobamides other than cobalamin when
cultured in the absence of an added lower ligand base.
This preference for DMB suggests that in some bacteria,
DMBmay be attachedwhen it is available in the environment
and could be an indication that cobalamin functions more
efficiently than their native cobamide. Our results further
show that adenine is the least preferred substrate for all of
the CobT enzymes, including two derived from bacteria
that produce [Ade]Cba when cultured without an added
lower ligand base. Together, our results suggest that the co-
bamide produced by bacteria in pure culturemay often differ
from the cobamide produced in the environment.
EXPERIMENTAL PROCEDURES
Molecular Techniques
To construct plasmids for the expression of CobT homologs fused to an N-ter-
minal hexahistidine tag, each cobT open reading frame was amplified by PCR
and cloned into the vector pET28a. For L. reuteri cobT, a codon-optimized
version in plasmid pMP220+Ptrp (Crofts et al., 2013) was used as the template
for PCR. For V. parvula arsAB, the arsA and arsB genes were amplified
together from V. parvula genomic DNA, and only arsA was fused to the
His tag. Escherichia coli strain DH5a was used for all cloning procedures.
Each plasmid was introduced into E. coli BL21(DE3) for expression and
purification.
Overexpression and Purification of CobT Enzyme Homologs
E. coli strain BL21(DE3) containing each CobT expression plasmid was grown
in LB medium containing 25 mg ml1 kanamycin at 37C with aeration at
180 rpm until the optical density at 600 nm (OD600) reached 0.6. Protein over-
expression was induced at 25C with aeration at 90 rpm for 16 hr by the addi-
tion of isopropyl-b-D-thiogalactopyranoside at a final concentration of 250 mM.
The cells were harvested by centrifugation, and the resulting cell pellets were
stored at80C. Cell pellets from 1 l of culture were resuspended in 30ml lysis
buffer (50mM sodium phosphate, 100mMNaCl, pH 8.0) and lysed by sonicat-
ion. The resulting cell lysate was clarified by centrifugation, and the CobT
protein was loaded onto a Ni-NTA column and purified according to the man-
ufacturer’s instructions (BioRad). After elution, the protein was transferred intolsevier Ltd All rights reserved
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(BioRad) and stored at 80C.
In Vitro Assay for CobT Enzyme Activity
Reactions were performed with 10 mM of the CobT enzyme, 2 mM NaMN 2,
10 mM MgCl2, and 250 mM of lower ligand base in 50 mM Tris-HCl pH 7.5
for the indicated time. Control reactions lacking enzyme, NaMN 2, or lower
ligand base were also conducted when each substrate was tested for the first
time. Reactions were quenched by the addition of formic acid at a final
concentration of 4% at 100C for 1 min. The quenched reaction was then
immediately placed on ice, and NaOH was added to each reaction at a final
concentration of 0.75 mM to raise the pH to 5. The precipitated protein was
removed by centrifugation prior to analysis by reverse-phase HPLC.
Analysis of the reactions was performed on an Agilent Technologies 1200
series HPLC system equipped with a diode array detector. An Agilent Eclipse
XDBC-18 column (5 mm, 4.63 150mm)was used at a flow rate of 1mlmin1 at
30C. Mobile phases used were 10 mM ammonium acetate pH 6.5 (solvent A)
and methanol (solvent B). Samples were analyzed by the following method:
0% solvent B over 2 min, followed by a linear gradient of 0% to 15% solvent
B over 1.5 min, 15% to 50% solvent B over 6.5 min, and 50% to 70% solvent
B over 2 min.
Chemical Analysis of a-Riboside Phosphate Products
LC-ESI-MS analysis of the reactions was performed on an Agilent Technolo-
gies 6410 liquid chromatograph-triple quadrupole mass spectrometer using
the chromatography method described above. Samples were analyzed using
an Agilent Eclipse XDB C-18 column (5 mm, 4.63 150 mm) or a Zorbax SB-Aq
column (5 mm, 4.6 3 150 mm) and separated at 1 ml min1 using the method
described above. The a-riboside phosphate products were detected using an
MS2 scan (gas flow rate 8.5 l min1, temperature 325C). To prepare samples
for one-dimensional 1H NMR analysis, SeCobT was used to generate each of
the a-riboside phosphate products except phenolyl-riboside phosphate (Phe-
RP 18) and p-cresolyl-riboside phosphate (Cre-RP 20), andVpArsABwas used
to produce Phe-RP 18 and Cre-RP 20, in 3 ml reactions. The products were
separated by HPLC as described above, and fractions were collected using
an Agilent 1200 series fraction collector connected in line with the HPLC.
The purified products were then lyophilized to dryness and resuspended in
100% D2O. The pH was measured to be 6–6.5 for all of the samples.
Determination of the Concentration of the a-Riboside Phosphate
Products
To determine the concentrations of the a-riboside phosphate products, 0.7–
1.8 mg of each a-riboside phosphate product was purified by HPLC from
large-scale CobT reactions. Each product was then subjected to ERETIC
NMR (Akoka et al., 1999). The electronic calibration signal for the concentra-
tion was generated with standard samples of 50 mM nicotinic acid 3 in tripli-
cate. The concentration of each sample was determined by comparison to
the electronic reference by using the nonexchangeable HD proton doublet
signal and the HA proton singlet signal. These samples were used to generate
standard curves with the HPLC method described above. The concentrations
of a-riboside phosphate reaction products analyzed by HPLC were deter-
mined by comparison of the peak areas with the standard curves.
In Vitro Competition Assays
Reactions were performed with 1 mMof enzyme, 2mMNaMN 2, and two lower
ligand substrates, each at 250 mM, in 50 mM Tris buffer pH 7.5 with 10 mM
MgCl2. Aliquots were quenched following 0 min, 1 min, 5 min, and 48 or
72 hr and analyzed by HPLC using a Zorbax SB-Aq column (5 mm, 4.6 3
150 mm) with the method described above.
In reactions in which one of the a-riboside phosphate products was not
detectable at 1 min, reactions were performed with the concentration of one
substrate increased to 5 mM.
To calculate the percent preference of each enzyme for DMB 1, the ratios of
the competing a-riboside phosphate products to a-RP 4 formed in each
competition reaction containing DMB 1 were calculated. The reciprocal of
the sum of these ratios plus the ratio of products formed if DMB 1 were
competed with itself (1) was expressed as a percent, indicating the preference
for DMB 1. The preferences for each of the other lower ligand substrates wereChemistry & Biology 20, 1275–1calculated similarly based on the ratios of the products of the remaining
competition reactions.
Competition Assay to Determine Relative Preferences for
Benzimidazoles in Si. meliloti
TheSi.meliloti bluB::gusGmR strain (Campbell et al., 2006) was used for in vivo
competition experiments. M9 minimal medium was supplemented with 1 mg
ml1 methionine, 10 ng ml1 biotin, and 10 mM CoCl2 (Maniatis et al., 1982).
For analysis of cobamides in the Si. meliloti cultures containing two benzimid-
azoles, 5 ml of M9 was inoculated with a colony of Si. meliloti grown on LBMC
(Maniatis et al., 1982) and incubated for 40–50 hr at 30C with aeration. These
cultures were diluted to an OD600 of 0.02 to 0.04 in 250 ml M9 containing both
DMB 1 and another benzimidazole at concentrations totaling 5 mM. Cells were
harvested following 48–60 hr of growth at 30C with aeration, and corrinoids
were extracted and analyzed by HPLC as described (Crofts et al., 2013). Con-
centrations of each cobamide were calculated based on integrated peaks
areas at 550 nm as compared to a standard curve of cyanocobalamin. SD50
values were determined by fitting the data to a sigmoidal curve using the
KaleidaGraph 4.0 (Synergy Software). The equation used for the sigmoidal fit
is y = m1 + (m2  m1)/(1 + (x/m3)^m4), where m1 and m2 are the maximum
and minimum normalized y-axis values (B12 produced) respectively, m3 is
the SD50, and m4 is the slope of the curve. The values for each individual fit
are reported in Table S3.
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